HUCOG 10000 HP Injection contains Human Chorionic Gonadotropin (hCG) at a concentration of 10,000 IU per vial. hCG is a glycoprotein hormone produced during pregnancy by the placental trophoblast and is structurally similar to luteinizing hormone (LH). HUCOG 10000 HP is primarily indicated for use in assisted reproductive technologies, including induction of ovulation and support of the luteal phase in women undergoing infertility treatment. It is also utilized in males for the treatment of hypogonadotropic hypogonadism to stimulate testosterone production and spermatogenesis. The injection is administered intramuscularly or subcutaneously as per the prescribed dosing regimen, which varies depending on the clinical indication and patient response. HUCOG 10000 HP works by mimicking the action of endogenous LH, thereby promoting follicular maturation and ovulation in females or stimulating Leydig cells in males. The medication should be used under strict medical supervision, with monitoring of hormone levels and clinical response to minimize adverse effects such as ovarian hyperstimulation syndrome (OHSS) in women or gynecomastia in men. Contraindications include hormone-sensitive tumors and hypersensitivity to hCG or any component of the formulation. Proper storage and handling are essential to maintain drug efficacy and safety.